Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health

References

• Mokoena MP. Lactic acid bacteria and their bacteriocins: classification, biosynthesis and applications against uropathogens: a mini-review. Molecules. 2017;22(8):1255. doi:10.3390/molecules22081255.
   PubMed Web of Science ®Google Scholar
• Turroni F, van Sinderen D, Ventura M. Genomics and ecological overview of the genus Bifidobacterium. Int J Food Microbiol. 2011;149(1):37–22. doi:10.1016/j.ijfoodmicro.2010.12.010.
   PubMed Web of Science ®Google Scholar
• Stiles ME, Holzapfel WH. Lactic acid bacteria of foods and their current taxonomy. Int J Food Microbiol. 1997;36(1):1–29. doi:10.1016/S0168-1605(96)01233-0.
   PubMed Web of Science ®Google Scholar
• Hugenholtz P, Chuvochina M, Oren A, Parks DH, Soo RM. Prokaryotic taxonomy and nomenclature in the age of big sequence data. ISME J. 2021;15(7):1879–1892. doi:10.1038/s41396-021-00941-x.
   PubMed Web of Science ®Google Scholar
• Klein G, Pack A, Bonaparte C, Reuter G. Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol. 1998;41(2):103–125. doi:10.1016/S0168-1605(98)00049-X.
   PubMed Web of Science ®Google Scholar
• Lukjancenko O, Ussery DW, Wassenaar TM. Comparative genomics of Bifidobacterium, Lactobacillus and related probiotic genera. Microb Ecol. 2012;63(3):651–673. doi:10.1007/s00248-011-9948-y.
   PubMed Web of Science ®Google Scholar
• Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. doi:10.1038/nrgastro.2014.66.
   PubMed Web of Science ®Google Scholar
• Helander HF, Fändriks L. Surface area of the digestive tract – revisited. Scand J Gastroenterol. 2014;49(6):681–689. doi:10.3109/00365521.2014.898326.
   PubMed Web of Science ®Google Scholar
• Corr SC, Gahan CCGM, Hill C. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. Fems Immunol Med Mic. 2008;52(1):2–12. doi:10.1111/j.1574-695X.2007.00359.x.
   PubMedGoogle Scholar
• Cesta MF. Normal structure, function, and histology of mucosa-associated lymphoid tissue. Toxicol Pathol. 2006;34(5):599–608. doi:10.1080/01926230600865531.
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med. 2005;11(S4):S45–S53. doi:10.1038/nm1213.
   PubMed Web of Science ®Google Scholar
• Moradi-Kalbolandi S, Majidzadeh-A K, Abdolvahab MH, Jalili N, Farahmand L. The role of mucosal immunity and recombinant probiotics in SARS-CoV2 vaccine development. Probiotics Antimicrob Proteins. 2021;13(5):1239–1253. doi:10.1007/s12602-021-09773-9.
   PubMed Web of Science ®Google Scholar
• Szatraj K, Szczepankowska AK, Chmielewska-Jeznach M. Lactic acid bacteria-promising vaccine vectors: possibilities, limitations, doubts. J Appl Microbiol. 2017;123(2):325–339. doi:10.1111/jam.13446.
   PubMed Web of Science ®Google Scholar
• Wyszynska A, Kobierecka P, Bardowski J, Jagusztyn-Krynicka EK. Lactic acid bacteria–20 years exploring their potential as live vectors for mucosal vaccination. Appl Microbiol Biotechnol. 2015;99(7):2967–2977. doi:10.1007/s00253-015-6498-0.
   PubMed Web of Science ®Google Scholar
• Plavec TV, Berlec A. Safety Aspects of Genetically Modified Lactic Acid Bacteria. Microorganisms. 2020;8(2):297.
   PubMed Web of Science ®Google Scholar
• Siegers K, Entian KD. Genes involved in immunity to the lantibiotic nisin produced by Lactococcus lactis 6F3. Appl Environ Microbiol. 1995;61(3):1082–1089. doi:10.1128/aem.61.3.1082-1089.1995.
   PubMed Web of Science ®Google Scholar
• Djordjevic GM, Klaenhammer TR. Inducible gene expression systems inLactococcus lactis. Mol Biotechnol. 1998;9(2):127–139. doi:10.1007/BF02760814.
   PubMed Web of Science ®Google Scholar
• Nouaille S, Ribeiro LA, Miyoshi A, Pontes D, Le Loir Y, Oliveira SC, Langella P, Azevedo V. Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res. 2003;2:102–111.
   PubMedGoogle Scholar
• Bermúdez-Humarán L, Corthier G, Langella P. Recent advances in the use of Lactococcus lactis as live recombinant vector for the development of new safe mucosal vaccines. Recent Res Dev Microbiol. 2004;8:147–160.
   Google Scholar
• Bolotin A, Wincker P, Mauger S, Jaillon O, Malarme K, Weissenbach J, Ehrlich SD, Sorokin A. The Complete Genome Sequence of the Lactic Acid Bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 2001;11(5):731–753. doi:10.1101/gr.169701.
   PubMed Web of Science ®Google Scholar
• Wegmann U, O’Connell-Motherway M, Zomer A, Buist G, Shearman C, Canchaya C, Ventura M, Goesmann A, Gasson MJ, Kuipers OP, et al. Complete Genome Sequence of the Prototype Lactic Acid Bacterium Lactococcus lactis subsp. cremoris MG1363. J Bacteriol. 2007;189(8):3256–3270. doi:10.1128/JB.01768-06.
   PubMed Web of Science ®Google Scholar
• Bermúdez-Humarán LG. Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins. Hum Vaccin. 2009;5(4):264–267. doi:10.4161/hv.5.4.7553.
   PubMed Web of Science ®Google Scholar
• Wells JM, Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol. 2008;6(5):349–362. doi:10.1038/nrmicro1840.
   PubMed Web of Science ®Google Scholar
• Leloir Y, Gruss A, Ehrlich SD, Langella P. Direct Screening of Recombinants in Gram-Positive Bacteria Using the Secreted Staphylococcal Nuclease as a Reporter. J Bacteriol. 1994;176(16):5135–5139. doi:10.1128/jb.176.16.5135-5139.1994.
   PubMed Web of Science ®Google Scholar
• de Ruyter Pg, Kuipers OP, Beerthuyzen MM, van Alen-boerrigter I, de Vos WM, de Ruyter PG. Functional analysis of promoters in the nisin gene cluster of Lactococcus lactis. J Bacteriol. 1996;178(12):3434–3439. doi:10.1128/jb.178.12.3434-3439.1996.
   PubMed Web of Science ®Google Scholar
• van Asseldonk M, de Vos Wm, Simons G, de Vos WM. Functional analysis of the Lactococcus lactis usp45 secretion signal in the secretion of a homologous proteinase and a heterologous α-amylase. Mol Gen Genet. 1993;240(3):428–434. doi:10.1007/BF00280397.
   PubMedGoogle Scholar
• Di Lorenzo A, Varcamonti M, Parascandola P, Vignola R, Bernardi A, Sacceddu P, Sisto R, de Alteriis E. Characterization and performance of a toluene-degrading biofilm developed on pumice stones. Microb Cell Fact. 2005;4(1):4. doi:10.1186/1475-2859-4-4.
   PubMedGoogle Scholar
• Piard JC, Hautefort I, Fischetti VA, Ehrlich SD, Fons M, Gruss A. Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J Bacteriol. 1997;179(9):3068–3072. doi:10.1128/jb.179.9.3068-3072.1997.
   PubMed Web of Science ®Google Scholar
• Song J, Zhao L, Song M. A lactococcus lactis-vectored oral vaccine induces protective immunity of mice against enterotoxigenic escherichia coli lethal challenge. Immunol Lett. 2020;225:57–63. doi:10.1016/j.imlet.2020.06.007.
   PubMed Web of Science ®Google Scholar
• van der Vossen Jm, van der Lelie D, Venema G, van der Vossen JM. Isolation and characterization of Streptococcus cremoris Wg2-specific promoters. Appl Environ Microbiol. 1987;53(10):2452–2457. doi:10.1128/aem.53.10.2452-2457.1987.
   PubMed Web of Science ®Google Scholar
• Clow F, Peterken K, Pearson V, Proft T, Radcliff FJ. PilVax, a novel Lactococcus lactis -based mucosal vaccine platform, stimulates systemic and mucosal immune responses to Staphylococcus aureus. Immunol Cell Biol. 2020;98(5):369–381. doi:10.1111/imcb.12325.
   PubMed Web of Science ®Google Scholar
• Rezaei M, Rabbani-Khorasgani M, Zarkesh-Esfahani SH, Emamzadeh R, Abtahi H. Lactococcus-based vaccine against brucellosis: igG immune response in mice with rOmp16-IL2 fusion protein. Arch Microbiol. 2021;203(5):2591–2596. doi:10.1007/s00203-021-02241-6.
   PubMed Web of Science ®Google Scholar
• Aliramaei MR, Khorasgani MR, Rahmani MR, Esfahani SHZ, Emamzadeh R. Expression of Helicobacter pylori CagL gene in Lactococcus lactis MG1363 and evaluation of its immunogenicity as an oral vaccine in mice. Microb Pathog. 2020;142:103926. doi:10.1016/j.micpath.2019.103926.
   Web of Science ®Google Scholar
• de Castro Cp, Souza BM, Mancha-Agresti P, Pereira VB, Zurita-Turk M, Preisser TM, de Castro CP, da Cunha VP, Dos Santos JSC, Leclercq SY, et al. Lactococcus lactis FNBPA+ (pValac:e6ag85a) Induces Cellular and Humoral Immune Responses After Oral Immunization of Mice. Front Microbiol. 2021;12:1222.
   Web of Science ®Google Scholar
• Mohseni AH, Taghinezhad-S S, Keyvani H. The First Clinical Use of a Recombinant Lactococcus lactis Expressing Human Papillomavirus Type 16 E7 Oncogene Oral Vaccine: a Phase I Safety and Immunogenicity Trial in Healthy Women Volunteers. Mol Cancer Ther. 2020;19(2):717–727. doi:10.1158/1535-7163.MCT-19-0375.
   PubMed Web of Science ®Google Scholar
• Diaz-Dinamarca DA, Hernandez C, Escobar DF, Soto DA, Muñoz GA, Badilla JF, Manzo RA, Carrión F, Kalergis AM, Vasquez AE, et al. Mucosal vaccination with lactococcus lactis-secreting surface immunological protein induces humoral and cellular immune protection against group b streptococcus in a murine model. Vaccines. 2020;8(2):146. doi:10.3390/vaccines8020146.
   Web of Science ®Google Scholar
• Xu P, Wang Y, Tao L, Wu X, Wu W. Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice. Biotechnol Lett. 2019;41(6–7):867–872. doi:10.1007/s10529-019-02695-1.
   PubMed Web of Science ®Google Scholar
• Lei H, Gao T, Cen Q. Cross-protective immunity of the haemagglutinin stalk domain presented on the surface of Lactococcus lactis against divergent influenza viruses in mice. Virulence. 2021;12(1):12–19. doi:10.1080/21505594.2020.1857162.
   PubMed Web of Science ®Google Scholar
• Zhou BY, Sun JC, Li X, Zhang Y, Luo B, Jiang N, Liu MC. Analysis of Immune Responses in Mice Orally Immunized with Recombinant pMG36e-SP-TSOL18/ Lactococcus lactis and pMG36e-TSOL18/ Lactococcus lactis Vaccines of Taenia solium. J Imm Res. 2018;2018:1–12. doi:10.1155/2018/9262631.
   Web of Science ®Google Scholar
• Singh SK, Plieskatt J, Chourasia BK, Singh V, Bolscher JM, Dechering KJ, Adu B, López-Méndez B, Kaviraj S, Locke E, et al. The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable. Journal of Biological Chemistry. 2020;295(2):403–414. doi:10.1074/jbc.RA119.011268.
   PubMed Web of Science ®Google Scholar
• Davarpanah E, Seyed N, Bahrami F, Rafati S, Safaralizadeh R, Taheri T, Bueno LL. Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice. PLoS Negl Trop Dis. 2020;14(1):e0007939. doi:10.1371/journal.pntd.0007939.
   PubMed Web of Science ®Google Scholar
• Torkashvand A, Bahrami F, Adib M, Ajdary S. Subcutaneous immunization with recombinant Lactococcus lactis expressing F1S1 fusion protein induces systemic and mucosal immune responses in BALB/C mice. Biochem Moler Bio. 2019;7:196.
   Google Scholar
• Kim EB, Piao da C, Son JS, Choi YJ. Cloning and characterization of a novel tuf promoter from Lactococcus lactis subsp. lactis IL1403. Curr Microbiol. 2009;59(4):425–431. doi:10.1007/s00284-009-9455-2.
   PubMed Web of Science ®Google Scholar
• Xuan B, Park J, Yoo JH, Kim EB. Oral Immunization of mice with cell extracts from recombinant Lactococcus lactis Expressing SARS-CoV-2 Spike Protein. Curr Microbiol. 2022;79(6):1–8. doi:10.1007/s00284-022-02866-w.
   Web of Science ®Google Scholar
• Temprana CF, Argüelles MH, Gutierrez NM, Barril PA, Esteban LE, Silvestre D, Mandile MG, Glikmann G, Castello AA, et al. Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model. PloS one. 2018;13(9):e0203700. doi:10.1371/journal.pone.0203700.
   PubMed Web of Science ®Google Scholar
• Kuipers OP, Beerthuyzen MM, de Ruyter Pg, Luesink EJ, de Vos WM, de Ruyter PGGA. Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J Biol Chem. 1995;270(45):27299–27304. doi:10.1074/jbc.270.45.27299.
   PubMed Web of Science ®Google Scholar
• Mierau I, Kleerebezem M. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol. 2005;68(6):705–717. doi:10.1007/s00253-005-0107-6.
   PubMed Web of Science ®Google Scholar
• Morello E, Bermudez-Humaran LG, Llull D, Sole V, Miraglio N, Langella P, Poquet I. Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J Mol Microbiol Biotechnol. 2008;14(1–3):48–58. doi:10.1159/000106082.
   PubMed Web of Science ®Google Scholar
• Benbouziane B, Ribelles P, Aubry C, Martin R, Kharrat P, Riazi A, Langella P, Bermúdez-Humarán LG. Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces. J Biotechnol. 2013;168(2):120–129. doi:10.1016/j.jbiotec.2013.04.019.
   PubMed Web of Science ®Google Scholar
• Carvalho RD, Do Carmo FLR, de Oliveira Junior A, Langella P, Chatel J-M, Bermúdez-Humarán LG, Azevedo V, de Azevedo MS. Use of wild type or recombinant lactic acid bacteria as an alternative treatment for gastrointestinal inflammatory diseases: a focus on inflammatory bowel diseases and mucositis. Front Microbiol. 2017;8:800. doi:10.3389/fmicb.2017.00800.
   PubMed Web of Science ®Google Scholar
• Tavares LM, De Jesus LCL, Da Silva TF, Barroso FAL, Batista VL, Coelho-Rocha ND, Azevedo V, Drumond MM, Mancha-Agresti P. Novel strategies for efficient production and delivery of live biotherapeutics and biotechnological uses of Lactococcus lactis: the lactic acid bacterium model. Front BioengiBiotech. 2020;8:1269. doi:10.3389/fbioe.2020.517166.
   Web of Science ®Google Scholar
• Miyoshi A, Jamet E, Commissaire J, Renault P, Langella P, Azevedo V. A xylose-inducible expression system for Lactococcus lactis. FEMS Microbiol Lett. 2004;239(2):205–212. doi:10.1016/j.femsle.2004.08.018.
   PubMed Web of Science ®Google Scholar
• de Azevedo Ms, Rocha CS, Electo N, Pontes DS, Molfetta JB, Goncalves ED, de Azevedo MSP, Azevedo V, Silva CL, Miyoshi A. Cytoplasmic and extracellular expression of pharmaceutical-grade mycobacterial 65-kDa heat shock protein in Lactococcus lactis. Genet Mol Res. 2012;11(2):1146–1157. doi:10.4238/2012.April.27.14.
   PubMed Web of Science ®Google Scholar
• Hollmann A, Saviello M, Delfederico L, Saraiva TD, Barh D, Jain N, Tiwari S, Chandra S, Gupta K, Zambare V, et al. Tight controlled expression and secretion of Lactobacillus brevis SlpA in Lactococcus lactis. Biotechnol Lett. 2012;34(7):1275–1281. doi:10.1007/s10529-012-0887-6.
   PubMed Web of Science ®Google Scholar
• Le Loir Y, Gruss A, Ehrlich SD, Langella P. A Nine-Residue Synthetic Propeptide Enhances Secretion Efficiency of Heterologous Proteins in Lactococcus lactis. J Bacteriol. 1998;180(7):1895–1903. doi:10.1128/JB.180.7.1895-1903.1998.
   PubMed Web of Science ®Google Scholar
• Morello E, Nouaille S, Cortes-Perez NG, Blugeon S, Medina LF, Azevedo V, Gratadoux JJ, Berm�dez-Humar�n LG, Le Loir Y, Langella P, et al. Inactivation of the ybdD Gene in Lactococcus lactis increases the amounts of exported proteins. Appl Environ Microbiol. 2012;78(19):7148–7151. doi:10.1128/AEM.01076-12.
   PubMed Web of Science ®Google Scholar
• Nouaille S, Morello E, Cortez-Peres N, Le Loir Y, Commissaire J, Gratadoux JJ, Poumerol E, Gruss A, Langella P. Complementation of the Lactococcus lactis secretion machinery with Bacillus subtilis SecDF Improves Secretion of Staphylococcal Nuclease. Appl Environ Microbiol. 2006;72(3):2272–2279. doi:10.1128/AEM.72.3.2272-2279.2006.
   PubMed Web of Science ®Google Scholar
• Poquet I, Saint V, Seznec E, Simoes N, Bolotin A, Gruss A. HtrA is the unique surface housekeeping protease in Lactococcus lactis and is required for natural protein processing. Mol Microbiol. 2000;35(5):1042–1051. doi:10.1046/j.1365-2958.2000.01757.x.
   PubMed Web of Science ®Google Scholar
• Frees D, Ingmer H. ClpP participates in the degradation of misfolded protein in Lactococcus lactis. Mol Microbiol. 1999;31(1):79–87. doi:10.1046/j.1365-2958.1999.01149.x.
   PubMed Web of Science ®Google Scholar
• Cortes-Perez NG, Poquet I, Oliveira M, Gratadoux JJ, Madsen SM, Miyoshi A, Corthier G, Azevedo V, Langella P, Bermúdez-Humarán LG, et al. Construction and characterization of a Lactococcus lactis strain deficient in intracellular ClpP and extracellular HtrA proteases. Micro Bio. 2006;152(9):2611–2618. doi:10.1099/mic.0.28698-0.
   Google Scholar
• Iwaki M, Okahashi N, Takahashi I, Kanamoto T, Sugita-Konishi Y, Aibara K, Koga T. Oral immunization with recombinant Streptococcus lactis carrying the Streptococcus mutans surface protein antigen gene. Infect Immun. 1990;58(9):2929–2934. doi:10.1128/iai.58.9.2929-2934.1990.
   PubMed Web of Science ®Google Scholar
• Wells JM, Wilson PW, Norton PM, Gasson MJ, Le Page RW. Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol. 1993;8:1155–1162.
   PubMed Web of Science ®Google Scholar
• Norton PM, Brown HW, Wells JM, Macpherson AM, Wilson PW, Le Page RW. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis. FEMS Immunol Med Microbiol. 1996;14(2–3):167–177. doi:10.1111/j.1574-695X.1996.tb00284.x.
   PubMedGoogle Scholar
• Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol. 1997;15:653–657.
   PubMed Web of Science ®Google Scholar
• Seegers JFML. Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol. 2002;20(12):508–515. doi:10.1016/S0167-7799(02)02075-9.
   PubMed Web of Science ®Google Scholar
• Allain T, Mansour NM, Bahr MMA, Martin R, Florent I, Langella P, Bermúdez-Humarán LG. A new lactobacilli in vivo expression system for the production and delivery of heterologous proteins at mucosal surfaces. FEMS Microbiol Lett. 2016;363(13):fnw117. doi:10.1093/femsle/fnw117.
   PubMed Web of Science ®Google Scholar
• Rush CM, Hafner LM, Timms PL. Vehicles for antigen delivery to the female urogenital tract. Advances in Mucosal Immunology, Pts a and B. 1995;371:1547–1552.
   Google Scholar
• Pouwels PH, Leer RJ, Boersma WJA. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J Biotechnol. 1996;44(1–3):183–192. doi:10.1016/0168-1656(95)00140-9.
   PubMed Web of Science ®Google Scholar
• Xue Y, Zhang B, Huang H-B, Li J-Y, Pan T-X, Tang Y, Shi C-W, Chen H-L, Wang N, Yang G-L, et al. Immunoprotective effects of invasive Lactobacillus plantarum delivered nucleic acid vaccine coexpressing Trichinella spiralis CPF1 and murine interleukin-4. Vet Parasitol. 2021;298:109556. doi:10.1016/j.vetpar.2021.109556.
   PubMed Web of Science ®Google Scholar
• Ding G, Bai J, Feng B, Wang L, Qiao X, Zhou H, Jiang Y, Cui W, Tang L, Li Y, et al. An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for Clostridium perfringens elicits effective anti-toxins protective immunity. Virulence. 2019;10(1):754–767. doi:10.1080/21505594.2019.1653720.
   PubMed Web of Science ®Google Scholar
• Wang S, Geng N, Zhou D, Qu Y, Shi M, Xu Y, Liu K, Liu Y, Liu J. Oral immunization of chickens with recombinant Lactobacillus plantarum vaccine against early ALV-J infection. Front Immunol. 2019;10:2299. doi:10.3389/fimmu.2019.02299.
   PubMed Web of Science ®Google Scholar
• Huang H, Jiang Y, Zhou F, Shi C, Yang W, Wang J, Kang Y, Cao X, Wang C, Yang G, et al. A potential vaccine candidate towards chicken coccidiosis mediated by recombinant Lactobacillus plantarum with surface displayed EtMIC2 protein. Exp Parasitol. 2020;215:107901. doi:10.1016/j.exppara.2020.107901.
   PubMed Web of Science ®Google Scholar
• Wang J, Jiang H, Yang R, Zhang S, Zhao W, Hu J, Jiang Y, Yang W, Huang H, Shi C, et al. Construction and evaluation of recombinant Lactobacillus plantarum NC8 delivering one single or two copies of G protein fused with a DC-targeting peptide (DCpep) as novel oral rabies vaccine. Vet Microbiol. 2020;251:108906. doi:10.1016/j.vetmic.2020.108906.
   PubMed Web of Science ®Google Scholar
• Wang L, Xia T, Guo T, Ru Y, Jiang Y, Cui W, Zhou H, Qiao X, Tang L, Xu Y, et al. Recombinant Lactobacillus casei expressing capsid protein vp60 can serve as vaccine against rabbit hemorrhagic disease virus in rabbits. Vaccines. 2019;7(4):172. doi:10.3390/vaccines7040172.
   Web of Science ®Google Scholar
• Kuczkowska K, Copland A, Øverland L, Mathiesen G, Tran AC, Paul MJ, Eijsink VGH, Reljic R. Inactivated Lactobacillus plantarum carrying a surface-displayed Ag85B-ESAT-6 fusion antigen as a booster vaccine against Mycobacterium tuberculosis infection. Front Immunol. 2019;10:1588. doi:10.3389/fimmu.2019.01588.
   PubMed Web of Science ®Google Scholar
• Shonyela SM, Shi C, Yang W, Cao X, Yang G, Wang C. Recombinant Lactobacillus plantarum NC8 strain expressing porcine rotavirus VP7 induces specific antibodies in BALB/c mice. Acta Biochim Biophys Sin (Shanghai). 2021;53(6):707–718. doi:10.1093/abbs/gmab050.
   PubMed Web of Science ®Google Scholar
• Pan N, Liu B, Bao X, Zhang H, Sheng S, Liang Y, Pan H, Wang X. Oral delivery of novel recombinant lactobacillus elicit high protection against staphylococcus aureus pulmonary and skin infections. Vaccines. 2021;9(9):984. doi:10.3390/vaccines9090984.
   Web of Science ®Google Scholar
• Zhang Z, Huang H-B, Jiang Y-L, Liu J, Gao X, Liu Y, Yang W-T, Shi C-W, Wang D, Wang J-Z, et al. Immunological evaluation of invasive Lactobacillus plantarum co-expressing EtMIC2 and chicken interleukin-18 against Eimeria tenella. Parasitol Res. 2020;119(9):2885–2895. doi:10.1007/s00436-020-06745-w.
   PubMed Web of Science ®Google Scholar
• Bai Y, Wang G, Qi H, Wang Y, Xu C, Yue L, Hou X, Yu L. Immunogenicity of 987P fimbriae of enterotoxigenic Escherichia coli surface-displayed on Lactobacillus casei. Res Vet Sci. 2020;128:308–314. doi:10.1016/j.rvsc.2019.12.016.
   PubMed Web of Science ®Google Scholar
• Li L, Wang M, Hao J, Han J, Fu T, Bai J, et al. Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2. Int J Biol Macromol. 2021;190:599–608. doi:10.1016/j.ijbiomac.2021.08.232.
   Web of Science ®Google Scholar
• Wells JM, Wilson PW, Norton PM, Gasson MJ, Lepage RWF. Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol. 1993;8:1155–1162.
   PubMed Web of Science ®Google Scholar
• Robinson K, Chamberlain LM, Schofield KM, Wells JM, LePage RWF. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol. 1997;15:653–657.
   PubMed Web of Science ®Google Scholar
• Maassen CBM, Laman JD, den Bak-glashouwer MJH, Tielen FJ, van Holten-neelen J, Hoogteijling L, Antonissen C, Leer RJ, Pouwels PH, Boersma WJA, et al. Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis. Vaccine. 1999;17(17):2117–2128. doi:10.1016/S0264-410X(99)00010-9.
   PubMed Web of Science ®Google Scholar
• Reveneau N, Geoffroy M-C, Locht C, Chagnaud P, Mercenier A. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine. 2002;20(13–14):1769–1777. doi:10.1016/S0264-410X(02)00027-0.
   PubMed Web of Science ®Google Scholar
• Cortes-Perez NG, Lefevre F, Corthier G, Adel-Patient K, Langella P, Bermudez-Humaran LG. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine. 2007;25(36):6581–6588. doi:10.1016/j.vaccine.2007.06.062.
   PubMed Web of Science ®Google Scholar
• Rochat T, Gratadoux -J-J, Gruss A, Corthier G, Maguin E, Langella P, van de Guchte M. Production of a heterologous nonheme catalase by lactobacillus casei: an efficient tool for removal of H 2 O 2 and Protection of Lactobacillus bulgaricus from Oxidative Stress in Milk. Appl Environ Microb. 2006;72(8):5143–5149. doi:10.1128/AEM.00482-06.
   PubMed Web of Science ®Google Scholar
• Watterlot L, Rochat T, Sokol H, Cherbuy C, Bouloufa I, Lefevre F, Gratadoux -J-J, Honvo-Hueto E, Chilmonczyk S, Blugeon S, et al. Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol. 2010;144(1):35–41. doi:10.1016/j.ijfoodmicro.2010.03.037.
   PubMed Web of Science ®Google Scholar
• Chang TLY, Chang C-H, Simpson DA, Xu Q, Martin PK, Lagenaur LA, Schoolnik GK, Ho DD, Hillier SL, Holodniy M, et al. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. P Natl Acad Sci USA. 2003;100(20):11672–11677. doi:10.1073/pnas.1934747100.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yu Q, Gao J, Yang Q. Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1. Clini and Vaccine Immu. 2012;19(2):174–179. doi:10.1128/CVI.05618-11.
   PubMedGoogle Scholar
• Pavan S, Hols P, Delcour J, Geoffroy M-C, Grangette C, Kleerebezem M, Mercenier A. Adaptation of The Nisin-Controlled Expression System In Lactobacillus Plantarum: A Tool To Study In Vivo Biological Effects. Appl Environ Microbiol. 2000;66(10):4427–4432. doi:10.1128/AEM.66.10.4427-4432.2000.
   PubMed Web of Science ®Google Scholar
• Shaw DM, Gaerthe B, Leer RJ, Van Der Stap J, Smittenaar C, Heijne Den Bak-Glashouwer M-J, Thole JER, Tielen FJ, Pouwels PH, Havenith CEG, et al. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli. Immunology. 2000;100(4):510–518. doi:10.1046/j.1365-2567.2000.00069.x.
   PubMed Web of Science ®Google Scholar
• Bermúdez-Humarán LG, Kharrat P, Chatel J-M, Langella P. Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact. 2011;10(S1):1–10. doi:10.1186/1475-2859-10-S1-S4.
   PubMedGoogle Scholar
• Kruger C, Hu YZ, Pan Q, Marcotte H, Hultberg A, Delwar D, van Dalen PJ, Pouwels PH, Leer RJ, Kelly CG, et al. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol. 2002;20(7):702–706. doi:10.1038/nbt0702-702.
   PubMed Web of Science ®Google Scholar
• Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sanchez B, Margolles A. Bifidobacteria and their health-promoting effects. Microbiology Spectrum. 2017;5(3):5.3. 21. doi:10.1128/microbiolspec.BAD-0010-2016.
   PubMed Web of Science ®Google Scholar
• Mauras A, Chain F, Faucheux A, Ruffié P, Gontier S, Ryffel B, Butel M-J, Langella P, Bermúdez-Humarán LG, Waligora-Dupriet A-J, et al. A new Bifidobacteria Expression SysTem (BEST) to produce and deliver interleukin-10 in Bifidobacterium bifidum. Front Microbiol. 2018;9:3075. doi:10.3389/fmicb.2018.03075.
   PubMed Web of Science ®Google Scholar
• Shirakawa T, Kitagawa K. Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine. Hum Vaccin Immunother. 2018;14(1):159–162. doi:10.1080/21645515.2017.1382787.
   PubMed Web of Science ®Google Scholar
• Hu B, Kou L, Li C, Zhu L-P, Fan Y-R, Wu Z-W, Wang -J-J, Xu G-X. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth. Cancer Gene Ther. 2009;16(8):655–663. doi:10.1038/cgt.2009.7.
   PubMed Web of Science ®Google Scholar
• Yu Z, Huang Z, Sao C, Huang Y, Zhang F, Ma G, Chen Z, Zeng Z, Qiwen D, Zeng W, et al. Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71. Arch Virol. 2013;158(5):1071–1077. doi:10.1007/s00705-012-1589-z.
   PubMed Web of Science ®Google Scholar
• Takei S, Omoto C, Kitagawa K, Morishita N, Katayama T, Shigemura K, Fujisawa M, Kawabata M, Hotta H, Shirakawa T, et al. Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice. Vaccine. 2014;32(25):3066–3074. doi:10.1016/j.vaccine.2014.03.022.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Wada J, Katayama T, Jikimoto T, Nakamura M, Kinoshita S, et al. Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model. Vaccine. 2010;28(41):6684–6691. doi:10.1016/j.vaccine.2010.08.007.
   PubMed Web of Science ®Google Scholar
• Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110(3):S4–S7. doi:10.1016/j.ygyno.2008.07.045.
   PubMed Web of Science ®Google Scholar
• Schiller JT, Castellsague X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine. 2008;26:K53–K61. doi:10.1016/j.vaccine.2008.06.002.
   PubMed Web of Science ®Google Scholar
• Metzger DW. IL-12 as an adjuvant for the enhancement of protective humoral immunity. Expert Rev Vaccines. 2009;8(5):515–518. doi:10.1586/erv.09.13.
   PubMed Web of Science ®Google Scholar
• Bermudez-Humaran LG, Langella P, Miyoshi A, Gruss A, Guerra RT, de Oca-luna RM, et al. Production of Human Papillomavirus Type 16 E7 Protein i Lactococcus lactis. Appl Environ Microb. 2002;68(2):917–922. doi:10.1128/AEM.68.2.917-922.2002.
   PubMed Web of Science ®Google Scholar
• Bermudez-Humaran LG, Cortes-Perez NG, Le Loir Y, Alcocer-Gonzalez JM, Tamez-Guerra RS, de Oca-luna RM, et al. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J Med Microbiol. 2004;53(5):427–433. doi:10.1099/jmm.0.05472-0.
   PubMed Web of Science ®Google Scholar
• Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. Journal of Neuroimmune Pharmacology. 2020;15(3):359–386. doi:10.1007/s11481-020-09944-5.
   PubMed Web of Science ®Google Scholar
• Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: the status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2021;170:1–25. doi:10.1016/j.addr.2020.12.011.
   PubMed Web of Science ®Google Scholar
• Mezhenskaya D, Isakova-Sivak I, Gupalova T, Bormotova E, Kuleshevich E, Kramskaya T, et al. a live probiotic vaccine prototype based on conserved influenza a virus antigens protect mice against lethal influenza virus infection. Biomedicines. 2021;9(11):1515. doi:10.3390/biomedicines9111515.
   PubMed Web of Science ®Google Scholar
• Gupalova T, Leontieva G, Kramskaya T, Grabovskaya K, Kuleshevich E, Suvorov A. Development of experimental pneumococcal vaccine for mucosal immunization. PloS one. 2019;14(6):e0218679. doi:10.1371/journal.pone.0218679.
   PubMed Web of Science ®Google Scholar
• Thinbanmai T, Lulitanond V, Mayo B, Lulitanond A, Panya M. Cloning and expression of enterovirus 71 capsid protein 1 in a probio Bifidobacterium pseudocatenulatum. Lett Appl Microbiol. 2019;68(1):9–16. doi:10.1111/lam.13089.
   PubMed Web of Science ®Google Scholar
• Jung K, Saif LJ, Wang Q. Porcine epidemic diarrhea virus (PEDV): an update on etiology, transmission, pathogenesis, and prevention and control. Virus Res. 2020;286:198045. doi:10.1016/j.virusres.2020.198045.
   PubMed Web of Science ®Google Scholar
• Hou X-L, L-y Y, Liu J, Wang G-H. Surface-displayed porcine epidemic diarrhea viral (PEDV) antigens on lactic acid bacteria. Vaccine. 2007;26(1):24–31. doi:10.1016/j.vaccine.2007.10.065.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang B, Zhang D, Liu S, Ren J. The construction of recombinant Lactobacillus casei vaccine of PEDV and its immune responses in mice. BMC Vet Res. 2021;17(1):1–10. doi:10.1186/s12917-021-02885-y.
   PubMed Web of Science ®Google Scholar
• Yu M, Wang L, Ma S, Wang X, Wang Y, Xiao Y, et al. Immunogenicity of eGFP-marked recombinant Lactobacillus casei against transmissible gastroenteritis virus and porcine epidemic diarrhea virus. Viruses. 2017;9(10):274. doi:10.3390/v9100274.
   PubMed Web of Science ®Google Scholar
• Lahiri A, Bhowmick S, Sharif S, Mallick AI. Pre-treatment with chicken IL-17A secreted by bioengineered LAB vector protects chicken embryo fibroblasts against Influenza Type A Virus (IAV) infection. Mol Immunol. 2021;140:106–119. doi:10.1016/j.molimm.2021.10.003.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang W, Song Y, Wang W, Zhang Y, Wang T, et al. Recombinant Lactococcus lactis co-expressing OmpH of an M cell-targeting ligand and IBDV-VP2 protein provide immunological protection in chickens. Vaccine. 2018;36(5):729–735. doi:10.1016/j.vaccine.2017.12.027.
   PubMed Web of Science ®Google Scholar
• Fleckenstein JM, Kuhlmann FM, Sheikh A. Acute Bacterial Gastroenteritis. GastrO Clin. 2021;50(2):283–304. doi:10.1016/j.gtc.2021.02.002.
   PubMed Web of Science ®Google Scholar
• Gorain C, Khan A, Singh A, Mondal S, Mallick AI. Bioengineering of LAB vector expressing Haemolysin co-regulated protein (Hcp): a strategic approach to control gut colonization of Campylobacter jejuni in a murine model. Gut Pathog. 2021;13(1):1–16. doi:10.1186/s13099-021-00444-2.
   PubMed Web of Science ®Google Scholar
• Ahmadi Rouzbahani H, Mousavi Gargari SL, Nazarian S, Abdollahi S. Protective immunity against enterotoxigenic escherichia coli by oral vaccination of engineered lactococcus lactis. Curr Microbiol. 2021;78(9):3464–3473. doi:10.1007/s00284-021-02601-x.
   PubMed Web of Science ®Google Scholar
• de Castro C P, Mendes Souza B, Mancha-Agresti P, Bastos Pereira V, Zurita-Turk M, Melo Preisser T, et al. Lactococcus lactis FNBPA+ (pValac: e6ag85a) induces cellular and humoral immune responses after oral immunization of mice. Front Microbiol. 2021;12:1222.
   Web of Science ®Google Scholar
• Gottstein B, Pozio E, Noìˆckler K. Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin Microbiol Rev. 2009;22(1):127–145. doi:10.1128/CMR.00026-08.
   PubMed Web of Science ®Google Scholar
• Abdellahi L, Iraji F, Mahmoudabadi A, Hejazi SH. Vaccination in leishmaniasis: a review article. Iran Biomed J. 2022;26(1):1. doi:10.52547/ibj.26.1.35.
   PubMedGoogle Scholar
• Hugentobler F, Di Roberto RB, Gillard J, Cousineau B. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection. Vaccine. 2012;30(39):5726–5732. doi:10.1016/j.vaccine.2012.07.004.
   PubMed Web of Science ®Google Scholar
• Varo R, Chaccour C, Bassat Q. Update on malaria. Medicina Clínica(English Edition). Medicina clinica. 2020;155(9):395–402. doi:10.1016/j.medcli.2020.05.010.
   PubMed Web of Science ®Google Scholar
• Singh SK, Roeffen W, Mistarz UH, Chourasia BK, Yang F, Rand KD, et al. Construct design, production, and characterization of Plasmodium falciparum 48/45 R0. 6C subunit protein produced in Lactococcus lactis as candidate vaccine. Microb Cell Fact. 2017;16(1):1–11. doi:10.1186/s12934-017-0710-0.
   PubMedGoogle Scholar
• Singh SK, Plieskatt J, Chourasia BK, Fabra-García A, Garcia-Senosiain A, Singh V, et al. A reproducible and scalable process for manufacturing a Pfs48/45 based Plasmodium falciparum transmission-blocking vaccine. Front Immunol. 2021;11:606266.
   PubMed Web of Science ®Google Scholar
• Singh SK, Plieskatt J, Chourasia BK, Singh V, Bengtsson KL, Reimer JM, et al. Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine. NPJ Vaccines. 2021;6(1):1–11. doi:10.1038/s41541-021-00383-8.
   PubMed Web of Science ®Google Scholar
• Mills RM. Chagas disease: epidemiology and barriers to treatment. Am J Med. 2020;133(11):1262–1265. doi:10.1016/j.amjmed.2020.05.022.
   PubMed Web of Science ®Google Scholar
• Quintana I, Espariz M, Villar SR, González FB, Pacini MF, Cabrera G, et al. Genetic engineering of Lactococcus lactis co-producing antigen and the mucosal adjuvant 3’ 5’-cyclic di adenosine monophosphate (c-di-AMP) as a design strategy to develop a mucosal vaccine prototype. Front Microbiol. 2018;9:2100. doi:10.3389/fmicb.2018.02100.
   PubMed Web of Science ®Google Scholar
• Ebrahimzadeh F, Shirdast H, Taromchi A, Talebkhan Y, Haniloo A, Esmaeilzadeh A, et al. Induction of immunogenic response in balb/c mice by live and killed form of recombinant Lactococcus lactis displaying EG95 of echinococcus granulosus. Iran Biomed J. 2021;25(4):284. doi:10.52547/ibj.25.4.284.
   PubMedGoogle Scholar
• Bermudez-Humaran LG, Langella P, Cortes-Perez NG, Gruss A, Tamez-Guerra RS, Oliveira SC, et al. intranasal immunization with recombinant lactococcus lactis secreting murine interleukin-12 enhances antigen-specific th1 cytokine production. Infect Immun. 2003;71(4):1887–1896. doi:10.1128/IAI.71.4.1887-1896.2003.
   PubMed Web of Science ®Google Scholar
• Bermudez-Humaran LG, Cortes-Perez NG, Lefevre F, Guimaraes V, Rabot S, Alcocer-Gonzalez JM, et al. A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. Journal of Immunology. 2005;175(11):7297–7302. doi:10.4049/jimmunol.175.11.7297.
   PubMed Web of Science ®Google Scholar
• Angkasekwinai P. Th9 cells in allergic disease. Curr Allergy Asthma Rep. 2019;19(5):1–9. doi:10.1007/s11882-019-0860-8.
   PubMed Web of Science ®Google Scholar
• Ai C, Zhang Q, Ren C, Wang G, Liu X, Tian F, et al. Genetically engineered Lactococcus lactis protect against house dust mite allergy in a BALB/c mouse model. PloS one. 2014;9(10):e109461. doi:10.1371/journal.pone.0109461.
   PubMed Web of Science ®Google Scholar
• Chan CJ, Yong YS, Song AAL, Abdul Rahim R, In LLA, Lim RLH. Lactococcus lactharbouring Ara h 2.02 alleviates allergen-specific Th2-associated responses in sensitized mice. J Appl Microbiol. 2020;128(3):862–874. doi:10.1111/jam.14524.
   PubMed Web of Science ®Google Scholar
• C-y W, Bermúdez-Humarán LG, Yue F, Li M, Zhang L-P. Intranasal administration with recombinant Lactococcus lactis expressing heme oxygenase-1 reduces hyperoxia-induced lung inflammation in rat pups. Biotechnol Lett. 2015;37(6):1203–1211. doi:10.1007/s10529-015-1795-3.
   PubMed Web of Science ®Google Scholar
• Martin R, Chain F, Natividad JM, Natividad JM, Sokol H. Effects in the use of a genetically engineered strain of Lactococcus lacti delivering in situ IL-10 as a therapy to treat low-grade colon inflammation. Hum Vaccin Immunother. 2014;10(6):1611–1621. doi:10.4161/hv.28549.
   PubMed Web of Science ®Google Scholar
• Hanson ML, Hixon JA, Li W, Felber BK, Anver MR, Stewart CA, et al. Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology. 2014;146(1):210–21. e13. doi:10.1053/j.gastro.2013.09.060.
   PubMed Web of Science ®Google Scholar
• Carvalho RD, Breyner N, Menezes-Garcia Z, Rodrigues NM, Lemos L, Maioli TU, et al. Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis. Microb Cell Fact. 2017;16(1):1–11. doi:10.1186/s12934-017-0624-x.
   PubMedGoogle Scholar
• Del Carmen S, de Moreno de Leblanc A, Perdigón G, Bastos Pereira V, Miyoshi A, Azevedo V, et al. Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing Lactococcus lactis using a murine model of Crohn`s disease. J Mol Microbiol Biotechnol. 2011;21(3–4):138–146. doi:10.1159/000333830.
   PubMed Web of Science ®Google Scholar
• LeBlanc JG, Del Carmen S, Miyoshi A, Azevedo V, Sesma F, Langella P, et al. Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn’s disease in mice. J Biotechnol. 2011;151(3):287–293. doi:10.1016/j.jbiotec.2010.11.008.
   PubMed Web of Science ®Google Scholar
• DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391(10138):2449–2462. doi:10.1016/S0140-6736(18)31320-5.
   PubMed Web of Science ®Google Scholar
• Liu K-F, Liu X-R, G-L L, S-P L, Jin L, Wu J. Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice. Immunol Lett. 2016;174:28–36. doi:10.1016/j.imlet.2016.04.008.
   PubMed Web of Science ®Google Scholar
• Cook DP, Cunha JPMCM, Martens P-J, Sassi G, Mancarella F, Ventriglia G, Sebastiani G, Vanherwegen A-S, Atkinson MA, Van Huynegem K, et al. Intestinal delivery of proinsulin and IL-10 via Lactococcus lactis combined with low-dose anti-CD3 restores tolerance outside the window of acute type 1 diabetes diagnosis. Front Immunol. 2020;11:1103. doi:10.3389/fimmu.2020.01103.
   PubMed Web of Science ®Google Scholar
• Preisser TM, da Cunha VP, Santana MP, Pereira VB, Cara DC, Souza BM, Miyoshi A. Recombinant Lactococcus lactis carrying IL-4 and IL-10 coding vectors protects against type 1 diabetes in NOD mice and attenuates insulitis in the STZ-induced model. J Diabetes Res. 2021;2021:1–15. doi:10.1155/2021/6697319.
   Web of Science ®Google Scholar
• Sand IK. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol. 2015;28(3):193–205. doi:10.1097/WCO.0000000000000206.
   PubMed Web of Science ®Google Scholar
• Rezende RM, Oliveira RP, Medeiros SR, Gomes-Santos AC, Alves AC, Loli FG, Guimarães MAF, Amaral SS, da Cunha AP, Weiner HL, et al. Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells. J Autoimmun. 2013;40:45–57. doi:10.1016/j.jaut.2012.07.012.
   PubMed Web of Science ®Google Scholar
• Szczepankowska K. Oral administration of Lactococcus lactis expressing synthetic genes of myelin antigens in decreasing experimental autoimmune encephalomyelitis in rats. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2015;21:1587. doi:10.12659/MSM.892764.
   PubMed Web of Science ®Google Scholar
• Kasarello K, Szczepankowska A, Kwiatkowska-Patzer B, Lipkowski AW, Gadamski R, Sulejczak D, Łachwa M, Biały M, Bardowski J. Effect of recombinantLactococcuslactis producing myelin peptides on neuroimmunological changes in rats with experimental allergic encephalomyelitis. Folia Neuropathologica. 2016;3:249–258. doi:10.5114/fn.2016.62534.
   Google Scholar
• Littlejohn EA, Monrad SU. Early diagnosis and treatment of rheumatoid arthritis. Primary Care: Clinics in Office Practice. 2018;45(2):237–255. doi:10.1016/j.pop.2018.02.010.
   PubMed Web of Science ®Google Scholar
• Maddaloni M, Kochetkova I, Hoffman C, Pascual DW. Delivery of IL-35 by Lactococcus lactis ameliorates collagen-induced arthritis in mice. Front Immunol. 2018;9:2691. doi:10.3389/fimmu.2018.02691.
   PubMed Web of Science ®Google Scholar
• Gusmao-Silva G, Aguiar SLF, Miranda MCG, Guimaraes MA, Alves JL, Vieira AT, et al. Hsp65-producing Lactococcocus lactis prevents antigen-induced arthritis in mice. Front Immunol. 2020;11:562905.
   PubMedGoogle Scholar
• Akgul A, Maddaloni M, Jun SM, Nelson AS, Odreman VA, Hoffman C, Bhagyaraj E, Voigt A, Abbott JR, Nguyen CQ, et al. Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome. Arthritis Res Ther. 2021;23(1):1–16. doi:10.1186/s13075-021-02475-1.
   PubMed Web of Science ®Google Scholar
• Bermudez-Humaraan LG, Nouaille S, Zilberfarb V, Corthier G, Gruss A, Langella P, Issad T. Effects of intranasal administration of a leptin-secreting lactococcus lactis recombinant on food intake, body weight, and immune response of mice. Appl Environ Microb. 2007;73(16):5300–5307. doi:10.1128/AEM.00295-07.
   PubMed Web of Science ®Google Scholar
• Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E. Treatment of murine colitis by lactococcus lactis secreting interleukin-10. Science. 2000;289(5483):1352–1355. doi:10.1126/science.289.5483.1352.
   PubMed Web of Science ®Google Scholar
• Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, Cox E, Remon JP, Remaut E. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol. 2003;21(7):785–789. doi:10.1038/nbt840.
   PubMed Web of Science ®Google Scholar
• Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJH, Neirynck S, Peppelenbosch MP, Steidler L, et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin Gastroenterol Hepatol. 2006;4(6):754–759. doi:10.1016/j.cgh.2006.03.028.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke K, Hans W, Van Huysse J, Neirynck S, Demetter P, Remaut E, Rottiers P, Steidler L. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology. 2004;127(2):502–513. doi:10.1053/j.gastro.2004.05.020.
   PubMed Web of Science ®Google Scholar
• Caluwaerts S, Vandenbroucke K, Steidler L, Neirynck S, Vanhoenacker P, Corveleyn S, Watkins B, Sonis S, Coulie B, Rottiers P, et al. AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol. 2010;46(7):564–570. doi:10.1016/j.oraloncology.2010.04.008.
   PubMed Web of Science ®Google Scholar
• Motta J-P, Bermudez-Humaran LG, Deraison C, Martin L, Rolland C, Rousset P, Boue J, Dietrich G, Chapman K, Kharrat P, et al. Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Transl Med. 2012;4(158):158ra44. doi:10.1126/scitranslmed.3004212.
   Web of Science ®Google Scholar